Technical Analysis for IPA - ImmunoPrecise Antibodies Ltd.

Grade Last Price % Change Price Change
F 0.39 -5.42% -0.02
IPA closed down 5.42 percent on Wednesday, November 20, 2024, on 26 percent of normal volume.
Earnings due: Dec 12
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
New 52 Week Closing Low Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Hammer Candlestick Bullish -5.42%
Narrow Range Bar Range Contraction -5.42%
Wide Bands Range Expansion -5.42%
Down 3 Days in a Row Weakness -5.42%

   Recent Intraday Alerts

Alert Time
Down 5% about 21 hours ago
Down 3% about 21 hours ago
Fell Below Previous Day's Low about 21 hours ago
Down 2 % about 21 hours ago
Down 1% about 21 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ImmunoPrecise Antibodies Ltd. Description

ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Immunology Antibodies Monoclonal Antibody Antibody Cloning Screening

Is IPA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.6
52 Week Low 0.3503
Average Volume 636,470
200-Day Moving Average 1.04
50-Day Moving Average 0.55
20-Day Moving Average 0.47
10-Day Moving Average 0.44
Average True Range 0.06
RSI (14) 34.21
ADX 19.08
+DI 16.30
-DI 22.52
Chandelier Exit (Long, 3 ATRs) 0.50
Chandelier Exit (Short, 3 ATRs) 0.54
Upper Bollinger Bands 0.61
Lower Bollinger Band 0.33
Percent B (%b) 0.21
BandWidth 60.57
MACD Line -0.04
MACD Signal Line -0.04
MACD Histogram -0.0006
Fundamentals Value
Market Cap 10.16 Million
Num Shares 26.3 Million
EPS -0.48
Price-to-Earnings (P/E) Ratio -0.80
Price-to-Sales 2.53
Price-to-Book 1.50
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.45
Resistance 3 (R3) 0.45 0.43 0.44
Resistance 2 (R2) 0.43 0.41 0.43 0.43
Resistance 1 (R1) 0.41 0.40 0.40 0.41 0.43
Pivot Point 0.39 0.39 0.38 0.39 0.39
Support 1 (S1) 0.37 0.37 0.36 0.36 0.34
Support 2 (S2) 0.34 0.36 0.34 0.34
Support 3 (S3) 0.32 0.34 0.33
Support 4 (S4) 0.32